Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic nephropathy.

K R Tuttle1

  • 1The Heart Institute of Spokane, Spokane, Washington 99204-2340, USA. ktuttle@this.org

Current Opinion in Nephrology and Hypertension
|February 27, 2001
PubMed
Summary
This summary is machine-generated.

Ischemic nephropathy, a cause of chronic kidney failure in older adults, involves renal artery stenosis. Revascularization is key, with percutaneous interventions offering new treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.

American journal of preventive cardiology·2026
Same author

Mind the gap in kidney care: translating what we know into what we do.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Albuminuria reduction: the holy grail for kidney protection.

Kidney international·2007
Same author

Diabetic nephropathy: implications for renal and cardiovascular outcomes.

Minerva medica·2004
Same author

Sex differences in uric acid and risk factors for coronary artery disease.

The American journal of cardiology·2001
Same author

Toward more rational management of ischemic nephropathy: the need for clinical evidence.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
Same journal

Updates in management of cardiorenal syndrome.

Current opinion in nephrology and hypertension·2026
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
See all related articles

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Interventional Radiology

Background:

  • Ischemic nephropathy is a significant cause of chronic renal failure in individuals over 50.
  • Renal artery stenosis, a common cause of ischemic nephropathy, is linked to increased mortality, especially with impaired renal or cardiac function.

Purpose of the Study:

  • To review the current understanding and management of ischemic nephropathy.
  • To highlight diagnostic modalities and therapeutic approaches, including revascularization.

Main Methods:

  • Diagnosis relies on clinical presentation and imaging studies.
  • Non-invasive screening tests like duplex Doppler ultrasound and magnetic resonance angiography are promising.

Main Results:

Related Experiment Videos

  • Revascularization is the primary therapy, despite limited controlled trial data.
  • Percutaneous interventions enable revascularization for a broader patient group, including surgical risks.

Conclusions:

  • Optimal medical therapies and revascularization strategies require further definition.
  • Further research is needed to establish best practices for managing ischemic nephropathy.